$CCAP

Crescent Capital BDC, Inc. (CCAP): Results of Operations and Financial Condition

Crescent Capital BDC, Inc. (CCAP) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ccap-ex99_1.htm EX-99.1 EX-99.1 Crescent Capital BDC, Inc. Reports Second Quarter 2026 Earnings Results; Declares a Third Quarter Base Dividend of $0.34 Per Share LOS ANGELES, August 10, 2026 — Crescent Capital BDC, Inc. (“Crescent BDC” or “Company”) (NASDAQ: CCAP) toda

Original reporting
Published Aug 10, 2026, 8:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 10, 2026, 8:19 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$CCAP
Neutral
medium confidence
Mentioned
$CCAP
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$CCAPNeutralMed
01

Why it matters

The key tradable items are the reported Q2 per-share earnings metrics, NAV per share, and the declared third-quarter regular dividend ($0.34/share) plus the second special dividend ($0.03/share).

02

Market read

Fresh quarterly results and dividend amounts can affect near-term positioning for BDC income strategies and NAV-focused valuation models.

03

What to watch

The income decline is attributed to lower Logan JV dividends and reduced prepayment/refinancing fees, so traders should watch whether that JV distribution trend reverses in coming quarters.

Relevance 7/10Novelty 7/10Timing: after-hours filing today, before the Aug 11 earnings webcast

Background

This is an SEC Form 8-K (Item 2.02) with Q2 2026 results and dividend declarations for Crescent Capital BDC, a NASDAQ-listed BDC.

Company-level read

Ticker impact

$CCAPNeutralMedium confidence
Context

Crescent Capital BDC reported Q2 2026 net investment income of $0.36/share, NAV of $17.82, and declared a $0.34 regular dividend plus a $0.03 special dividend.

Expected impact

Likely modest, dividend/NAV-sensitive reaction rather than a major repricing, absent guidance or credit-event surprises in the excerpt.

Evidence & confidence

The article discloses quarterly results, NAV, and declared dividends, but it does not include new forward guidance, refinancing outcomes, or material credit deterioration beyond the reported net realized/unrealized movements.

Market effects

BDC sector traders may use the NAV and dividend declaration as a read-through for income durability and credit performance expectations.

None indicated beyond the company’s Los Angeles base.

Limited, as the disclosure is company-specific and not tied to global macro or cross-border events.

Counterpoint

The NAV decline versus March 31 (from $18.27 to $17.82) and negative net increase in net assets from operations (-$3.3m) could outweigh the dividend headline for total-return investors.

Key entities

  • Crescent Capital BDC, Inc.

    Reports Q2 2026 net investment income of $0.36/share, NAV of $17.82, and declares dividends for Q3 2026 and a special payment.

  • Logan JV investment

    The filing attributes lower dividend income to reduced distributions from the Company’s Logan JV investment.

  • Board of Directors

    Declared the third-quarter 2026 regular cash dividend of $0.34/share and the second special dividend of $0.03/share.

Related articles

$BARKMedAI 8/10

Why Are Bark (BARK) Shares Soaring Today

Bark (NYSE:BARK) shares rose 17.4% after its Q2 2026 results showed improving profitability despite weaker revenue. Revenue fell 23.4% to $78.82 million, while operating margin turned positive at 0.1% versus -8.1% a year earlier. Adjusted EBITDA was $612,000. Next-quarter revenue guidance was $84 million below estimates, but full-year EBITDA guidance was $8.5 million above expectations.

$RKLBMedAI 8/10

Rocket Lab (RKLB) Q2 2026: Record Revenue, Acquisitions Dent EPS

Rocket Lab reported Q2 2026 revenue of $234.07M, above the $230.94M consensus, up 62% year over year. Product revenue rose to $181.35M. GAAP EPS was -$0.08 versus -$0.0767, with the miss linked to $8.6M acquisition-related transaction costs. Backlog grew to $2.36B and Q3 revenue guidance was $250M-$265M.

$RKLBMedAI 8/10

Rocket Lab Just Delivered Record Results. So Why Is the Stock Sinking?

Rocket Lab (RKLB) reported Q2 record revenue of $234 million, up 62% year over year, and a net loss of $49 million, or $0.08 per share. Revenue beat consensus ($231.6 million) but loss was wider than expected ($0.03). Backlog rose 137% to $2.36 billion, with $1B+ new contracts and $397 million U.S. Space Force Flatellites deal. Q3 revenue guidance is $250-$265 million.

$RKLBHighAI 8/10

Live: Will Rocket Lab Soar Back to All-Time Highs After Q2 Earnings Tonight?

Rocket Lab (NASDAQ:RKLB) is set to report Q2 FY2026 earnings on Aug. 10. Management guided Q2 revenue to $225M-$240M, about 60% YoY growth, supported by a $2.2B backlog and recent defense contract wins including a $266M Space Force suborbital contract and $397M Flatellites award. The article highlights Neutron timing and margin deceleration as key investor focus.

$ALCMedAI 9/10

Alcon Q2 2026: EPS Beats by 11%, Guidance Raised Despite $402M Charge

Alcon reported Q2 2026 adjusted diluted EPS of $0.84, up 11.2% versus the $0.76 consensus, on net sales of $2.78B, 7.2% higher year over year and slightly above the $2.77B estimate. A $402M pre-tax impairment charge related to discontinuing PowerVision programs drove GAAP EPS to $0.00. Alcon raised full-year 2026 core EPS growth guidance to 12% to 15% constant currency and reiterated sales growth of 5% to 7%.

$SMCIMed

Supermicro to report Q4 results in latest test for AI infrastructure company

Supermicro (SMCI) will report Q4 results after the bell Tuesday. In a late-month update, it raised expected margins to 15% to 17% from prior 8.2% to 8.4% and said new Q4 orders exceed $60 billion. Bloomberg expects adjusted EPS of $1.33 on $11.2 billion revenue. SMCI also raised up to $7 billion in equity-linked financing and faces a DOJ export-controls probe involving its co-founder.